Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects

Abstract

OBJECTIVEIndividuals with type 2 diabetes have a myriad of metabolic aberrations including increased inflammation, increasing their cardiovascular risk. Toll-like receptors (TLRs) and their ligands play a key role in insulin resistance and atherosclerosis. However, there is a paucity of data examining the expression and activity of TLRs in type 2 diabetes. Thus, in the present study, we examined TLR2 and TLR4 mRNA and protein expression, their ligands, and signaling in monocytes of recently diagnosed type 2 diabetic patients.RESEARCH DESIGN AND METHODSTLR mRNA, protein expression, TLR ligands, and TLR signaling were measured in freshly isolated monocytes from healthy human control subjects (n = 23) and type 2 diabetic subjects (n = 23) using real-time RT-PCR, Western blot, and flow cytometric assays.RESULTSType 2 diabetic subjects had significantly increased TLR2, TLR4 mRNA, and protein in monocytes compared with control subjects (P < 0.05). Increased TLR2 and TLR4 expression correlated with BMI, homeostasis model assessment–insulin resistance (HOMA-IR), glucose, A1C, Nε-(carboxymethyl) lysine (CML), and free fatty acid (FFA). Ligands of TLR2 and TLR4, namely, HSP60, HSP70, HMGB1, endotoxin, and hyaluronan levels, were elevated in type 2 diabetic subjects and positively correlated with TLR2 and TLR4. Type 2 diabetic subjects showed increased MyD88, phosphorylated IRAK-1, Trif, TICAM-1, IRF-3, and NF-κB p65 expression in monocytes compared with control subjects. Furthermore, TLR-MyD88-NF-κB signaling resulted in elevated levels of cytokines (P < 0.05), but increased interleukin (IL)-1β, interferon (IFN)-γ, and endotoxin were not significant when adjusted for BMI.CONCLUSIONSIn this comprehensive study, we make the novel observation that TLR2 and TLR4 expression and their ligands, signaling, and functional activation are increased in recently diagnosed type 2 diabetes and contribute to the proinflammatory state.

Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus

“…Second, HSP70 activation of the TLR4 ligand on CD4 1 CD25 1 T cells is attributed to an increase in suppressive activity of these T cells in atherosclerosis. 82,83 Furthermore, HSP70 has been indicated to have a negative feedback effect on NF-kB signaling activity. 84 HSP70 has also been demonstrated to switch off TNF receptor-associated factor 6.…”

Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling

“…Some evidence indicates that the TLR4 levels are elevated in diabetes and its complications [11][12][13] . The increased expression of TLR4 induced by hyperglycemia results in the generation and secretion of a series of proinflammatory cytokines in adipocytes, monocytes, macrophages, and glomerular endothelial cells, among others [14,15] .…”

TLR4 polymorphisms seem not to be associated with prediabetes and type 2 diabetes but predispose to diabetic retinopathy; TLR4 polymorphisms in glucose continuum

“…Th us TLR2 and TLR4 have been implicated to participate in progress of insulin resistance (Shi et al 2006). Hyperglycemia is associated with their stimulation and studies have demonstrated they are overexpressed in patients with diabetes -both the type 1 ) and the type 2 (Dasu et al 2010).…”